News

AFCR CEO & Founder Dr. Sujuan Ba has been awarded the Inaugural Leadership Award for Global Advocate of Cancer Research at BIOHK2023

Sujuan Ba, Ph.D. has been awarded the Leadership Award for Global Advocate of Cancer Research by the Hong Kong Biotechnology Organization (HKBIO) at their BIOHK2023 Conference (13-16 September, Hong Kong Convention and Exhibition Centre). Dr. Ba is the President, CEO and Founder of the Asian Fund for Cancer Research, CEO…...

Read more

CityU and Asian Fund for Cancer Research sign MoU to boost biomedical innovation

Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) of CityU (second from right) and Dr Sujuan Ba (second from left) signed the MoU, witnessed by Mr Lester Garson Huang, Council Chairman of CityU (first from right), and Ms Lillian Cheong, Under Secretary for Innovation, Technology and Industry, HKSAR Government…...

Read more

USCACA – AFCR 2023 Young Investigator Awards

The U.S. Chinese Anti-Cancer Association (USCACA) and AFCR are pleased to invite nominations for the USCACA-­‐AFCR 2023 Young Investigator Awards. The Awards will recognize 3 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research. Candidacy is open to all Chinese researchers who…...

Read more

AFCR Takes Center Stage at the Nasdaq Closing Bell Ceremony

  Standing Together for a Greater Cause In a remarkable display of unity, Dr. Sujuan B., CEO of the Asian Fund for Cancer Research (AFCR), and Dr. Kwok Leung, CFO, proudly stood shoulder to shoulder with the Global Coalition for Adaptive Research (GCAR), esteemed partners, brave patients, and dedicated advocates…...

Read more

AFCR’s South Pole Trek for Cancer Research

  Join AFCR Chairman, Lance Kawaguchi, on an extraordinary journey to the South Pole this December as he takes on the ultimate challenge of walking 14,871 steps each day, symbolizing the 14,871 lives lost to cancer in Hong Kong to raise awareness and vital funds for cancer research.  This enduring…...

Read more

AFCR Launches the Double Your Impact Campaign in Partnership with Hugill & Ip

FOR IMMEDIATE RELEASE: 1 February 2023 CONTACTS: Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: marco.raccuia@hugillandip.com World Cancer Day – held every 4 February – is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action, UICC partners…...

Read more

Be a Spark of Hope for Cancer Patients – Renew Your Support Today!

As the year comes to a close, I wanted to reach out and ask for your support in our year-end fundraising campaign. Your generosity has the power to ignite a spark of hope for cancer patients and their families who are fighting an incredibly difficult battle. Your contribution will make a real difference…...

Read more

AFCR Annual Reception: A Community Effort to Find Cures for Cancer

On December 15, 2022, the Asian Fund for Cancer Research (AFCR) held its annual reception for community support of cancer research in Hong Kong. The event was a great success, thanks to the support of generous donors, attendees, and inspiring speakers who shared their thoughts on the importance of cancer…...

Read more

AFCR Mourns the Loss of Scientific Advisory Board Member Professor George Tsao

The Asian Fund for Cancer Research Limited (AFCR) is saddened by the loss of George Sai Wah Tsao, Ph.D., who was a professor at the School of Biomedical Sciences and the Director of the Faculty Core Facility of the Faculty of Medicine at the University of Hong Kong. Professor Tsao…...

Read more

94% of the U.S. population has been infected with the new coronavirus

By November 10, 2022, 94% (95% CrI, 79%-99%) of the US population were estimated to have been infected by SARS-CoV-2 at least once. Combined with vaccination, 97% (95%-99%) were estimated to have some prior immunological exposure to SARS-CoV-2. Between December 1, 2021 and November 10, 2022, protection against a new…...

Read more